Trials / Completed
CompletedNCT06949072
A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries
A Randomized, Single-Blind, Cross-Over Clinical Study to Assess an Experimental Dentifrice in an in Situ Model of Early Stage Caries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- HALEON · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the relative efficacy of an experimental dentifrice containing 1150 parts per million (ppm) fluoride (as sodium fluoride \[NaF\]) to remineralize early stage caries type lesions in an in situ model compared to a negative control and a reference dentifrice.
Detailed description
This is a randomized, single-blind, single-center, controlled, three period, three treatment, cross-over caries in situ model in healthy participants who wear a suitable removable mandibular partial denture. The denture will be modified to accommodate 2 gauze-covered, 4 millimeter (mm) round specimens of bovine dental enamel that have been previously demineralized in vitro to form artificial caries lesions. After 14 days of twice daily product use off-site, the specimens will be removed at the study site to determine the remineralization ability of the treatments. The same procedure will be followed for period 2 and 3 with a washout period of 2-3 days prior to each treatment period. Sufficient participants will be screened to randomize up to 50 participants to the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test Dentifrice | Dentifrice containing 5 percent (%) weight by weight (w/w) Potassium nitrate (KNO3) and 1150ppm fluoride as sodium fluoride. |
| DRUG | Reference Dentifrice | Dentifrice containing 1100ppm fluoride as stannous fluoride. |
| DRUG | Negative Control Dentifrice | Dentifrice containing 5% KNO3 with no fluoride. |
Timeline
- Start date
- 2025-04-28
- Primary completion
- 2025-09-11
- Completion
- 2025-09-11
- First posted
- 2025-04-29
- Last updated
- 2025-09-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06949072. Inclusion in this directory is not an endorsement.